A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

A New York City hospital system is slashing new-patient appointment times to 20 minutes from 40. That's dangerous, a ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

The rise in misconduct allegations is in part the result of a new era of “scientific sleuths” who comb through scientific ...

Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find ...

WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...

FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...

STAT's podcast The Readout LOUD this week discusses cannabinoid receptor drugs in weight loss, what the Fed's rates cut might ...

A Senate committee voted to hold Ralph de la Torre, CEO of troubled Steward Health Care, in contempt. If the full Senate ...

A House committee on Wednesday passed a bill to renew a program aimed at aiding development of drugs for rare diseases in ...